339 related articles for article (PubMed ID: 28988254)
1. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
[TBL] [Abstract][Full Text] [Related]
2. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Leukocytosis as a Prognostic Marker in Endometrioid-Type Endometrial Cancer: A Single-Center Experience from Saudi Arabia.
Salem H; Abu-Zaid A; Aloman O; Abuzaid M; Alsabban M; Elhassan T; Salem A; Alyamani Y; Al-Badawi IA
Gulf J Oncolog; 2020 Jan; 1(32):51-58. PubMed ID: 32342919
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
7. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.
Okunade KS; Dawodu O; Adenekan M; Nwogu CM; Awofeso O; Ugwu AO; Salako O; John-Olabode S; Olowoselu OF; Anorlu RI
Niger J Clin Pract; 2020 Aug; 23(8):1141-1147. PubMed ID: 32788493
[TBL] [Abstract][Full Text] [Related]
8. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
9. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
10. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.
Gorelick C; Andikyan V; Mack M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2009 Nov; 19(8):1384-9. PubMed ID: 20009894
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
[TBL] [Abstract][Full Text] [Related]
13. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
14. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
Han KH; Kim HS; Lee M; Chung HH; Song YS
Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
[TBL] [Abstract][Full Text] [Related]
17. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I
BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712
[TBL] [Abstract][Full Text] [Related]
18. Impact of lymphadenectomy in uterine endometrioid carcinoma.
Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
[TBL] [Abstract][Full Text] [Related]
19. Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis.
Haley L; Burmeister C; Buekers T; Elshaikh MA
Int J Gynecol Cancer; 2017 Mar; 27(3):479-485. PubMed ID: 28060139
[TBL] [Abstract][Full Text] [Related]
20. The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.
Lim S; Kim YH; Lee KB; Lee JM
J Gynecol Oncol; 2018 Sep; 29(5):e72. PubMed ID: 30022635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]